BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 25426714)

  • 1. Sildenafil citrate for prophylaxis of nephropathy in an animal model of contrast-induced acute kidney injury.
    Lauver DA; Carey EG; Bergin IL; Lucchesi BR; Gurm HS
    PLoS One; 2014; 9(11):e113598. PubMed ID: 25426714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 15-Hydroxyprostaglandin dehydrogenase inhibitor prevents contrast-induced acute kidney injury.
    Kim BW; Kim HJ; Kim SH; Baik HJ; Kang MS; Kim DH; Markowitz SD; Kang SW; Bae KB
    Ren Fail; 2021 Dec; 43(1):168-179. PubMed ID: 33459127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sildenafil obviates ischemia-reperfusion injury-induced acute kidney injury through peroxisome proliferator-activated receptor γ agonism in rats.
    Mohey V; Singh M; Puri N; Kaur T; Pathak D; Singh AP
    J Surg Res; 2016 Mar; 201(1):69-75. PubMed ID: 26850186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous sildenafil citrate and post-cardiac surgery acute kidney injury: a double-blind, randomised, placebo-controlled trial.
    Kumar T; Aujla H; Woźniak M; Dott W; Sullo N; Joel-David L; Pais P; Smallwood D; Miller D; Eagle-Hemming B; Di Paola AS; Barber S; Brookes C; Brunskill NJ; Murphy GJ
    Br J Anaesth; 2020 Jun; 124(6):693-701. PubMed ID: 32245569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology of Contrast-Induced Acute Kidney Injury (CIAKI).
    Vlachopanos G; Schizas D; Hasemaki N; Georgalis A
    Curr Pharm Des; 2019; 25(44):4642-4647. PubMed ID: 31820694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-acethyl-cysteine reduces the occurrence of contrast-induced acute kidney injury in patients with renal dysfunction: a single-center randomized controlled trial.
    Heguilén RM; Liste AA; Payaslian M; Ortemberg MG; Albarracín LM; Bernasconi AR
    Clin Exp Nephrol; 2013 Jun; 17(3):396-404. PubMed ID: 23138396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of contrast-induced acute kidney injury definition on clinical outcomes.
    Budano C; Levis M; D'Amico M; Usmiani T; Fava A; Sbarra P; Burdese M; Segoloni GP; Colombo A; Marra S
    Am Heart J; 2011 May; 161(5):963-71. PubMed ID: 21570530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased plasma osmolar gap is predictive of contrast-induced acute kidney injury.
    Kim S; Sung J; Kang WC; Ahn SY; Kim DK; Chin HJ; Na KY; Joo KW; Chae DW; Han JS
    Tohoku J Exp Med; 2012 Oct; 228(2):109-17. PubMed ID: 22976551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Febuxostat exerts dose-dependent renoprotection in rats with cisplatin-induced acute renal injury.
    Fahmi AN; Shehatou GS; Shebl AM; Salem HA
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):819-30. PubMed ID: 27215580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-induced kidney injury: how does it affect long-term cardiac mortality?
    Andreis A; Budano C; Levis M; Garrone P; Usmiani T; D'Ascenzo F; De Filippo O; D'Amico M; Bergamasco L; Biancone L; Marra S; Colombo A; Gaita F
    J Cardiovasc Med (Hagerstown); 2017 Nov; 18(11):908-915. PubMed ID: 28678146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal insufficiency following contrast media administration trial III: Urine flow rate-guided versus left-ventricular end-diastolic pressure-guided hydration in high-risk patients for contrast-induced acute kidney injury. Rationale and design.
    Briguori C; D'Amore C; De Micco F; Signore N; Esposito G; Napolitano G; Focaccio A;
    Catheter Cardiovasc Interv; 2020 Apr; 95(5):895-903. PubMed ID: 31282129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and outcomes of contrast-induced AKI following computed tomography.
    Weisbord SD; Mor MK; Resnick AL; Hartwig KC; Palevsky PM; Fine MJ
    Clin J Am Soc Nephrol; 2008 Sep; 3(5):1274-81. PubMed ID: 18463172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma neutrophil-gelatinase-associated lipocalin and cystatin C could early diagnose contrast-induced acute kidney injury in patients with renal insufficiency undergoing an elective percutaneous coronary intervention.
    Liu XL; Wang ZJ; Yang Q; Yu M; Shen H; Nie B; Han HY; Gao F; Zhou YJ
    Chin Med J (Engl); 2012 Mar; 125(6):1051-6. PubMed ID: 22613530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphodiesterase-5 inhibitors ameliorate structural kidney damage in a rat model of contrast-induced nephropathy.
    Iordache AM; Buga AM; Albulescu D; Vasile RC; Mitrut R; Georgiadis G; Zisis IE; Mamoulakis C; Tsatsakis A; Docea AO; Calina D
    Food Chem Toxicol; 2020 Sep; 143():111535. PubMed ID: 32622850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of phosphodiesterase 5 inhibitor sildenafil on the respiratory parameters, inflammation and apoptosis in a saline lavage-induced model of acute lung injury.
    Kosutova P; Mikolka P; Balentova S; Kolomaznik M; Adamkov M; Mokry J; Calkovska A; Mokra D
    J Physiol Pharmacol; 2018 Oct; 69(5):. PubMed ID: 30683832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-induced acute kidney injury following coronary angiography: a cohort study of hospitalized patients with or without chronic kidney disease.
    Neyra JA; Shah S; Mooney R; Jacobsen G; Yee J; Novak JE
    Nephrol Dial Transplant; 2013 Jun; 28(6):1463-71. PubMed ID: 23585585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention, incidence, and outcomes of contrast-induced acute kidney injury.
    Weisbord SD; Mor MK; Resnick AL; Hartwig KC; Sonel AF; Fine MJ; Palevsky PM
    Arch Intern Med; 2008 Jun; 168(12):1325-32. PubMed ID: 18574090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirtuin 3 deficiency aggravates contrast-induced acute kidney injury.
    Zhang Q; Liu X; Li N; Zhang J; Yang J; Bu P
    J Transl Med; 2018 Nov; 16(1):313. PubMed ID: 30445987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum and Tissue HIF-2 Alpha Expression in CIN, N-Acetyl Cysteine, and Sildenafil-Treated Rat Models: An Experimental Study.
    Altintop I; Tatli M; Karakukcu C; Soyer Sarica Z; Hanım Yay A; Balcioglu E; Ozturk A
    Medicina (Kaunas); 2018 Jul; 54(4):. PubMed ID: 30344285
    [No Abstract]   [Full Text] [Related]  

  • 20. Captopril for prevention of contrast-induced nephropathy in diabetic patients: a randomised study.
    Gupta RK; Kapoor A; Tewari S; Sinha N; Sharma RK
    Indian Heart J; 1999; 51(5):521-6. PubMed ID: 10721643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.